Adenoviral expression of the cyclin-dependent kinase inhibitor p27Kip1: a strategy for breast cancer gene therapy

J Natl Cancer Inst. 1998 Dec 2;90(23):1836-8. doi: 10.1093/jnci/90.23.1836.

Authors

A N Rakkar¹, Z Li, Y Katayose, M Kim, K H Cowan, P Seth

Affiliation

¹ Medical Breast Cancer Section, Medicine Branch, Division of Clinical Sciences, National Cancer Institute, Bethesda, MD 20892-1906, USA.

PMID: 9839525
DOI: 10.1093/jnci/90.23.1836

No abstract available

MeSH terms

Adenoviridae*
Animals
Breast Neoplasms / genetics
Breast Neoplasms / therapy*
Cyclin-Dependent Kinases / antagonists & inhibitors*
Enzyme Inhibitors / administration & dosage
Enzyme Inhibitors / metabolism*
Female
Gene Expression Regulation, Enzymologic
Genetic Therapy / methods*
Genetic Vectors*
Humans
Injections, Intralesional
Mammary Neoplasms, Experimental / genetics
Mammary Neoplasms, Experimental / therapy*
Mice
Mice, Nude

Substances

Enzyme Inhibitors
Cyclin-Dependent Kinases